ArticleslgStudy

science

XBiotech

XBiotech is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand XBiotech rather than just read about it. In short: XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

XBiotech — main illustration
XBiotech — illustration

Key takeaways

  • XBiotech belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect XBiotech to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of XBiotech from memory before moving on to harder problems.

Reference excerpt

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

History XBiotech was founded in 2005 in Vancouver, Canada by John Simard. The company moved its headquarters to Austin, Texas in 2008. In September 2016, XBiotech was listed on Nasdaq, raising $70.9 million through its initial public offering (IPO). The company allocated about $42 million of the proceeds to complete later-stage trials for one of its key cancer drugs and to construct a new manufacturing and research facility in southeast Austin. The remaining funds were used for earlier-stage trials of other products and general corporate purposes. In March 2017, XBiotech announced a registered direct offering in which it sold over $30 million of its common shares at a price of $13 per share. In the same year, XBiotech opened a 40,000-square-foot production facility in Southeast Austin. In October 2017, XBiotech enrolled its first patient in a clinical study to evaluate the effectiveness of its antibody MABp1 in combination with ONIVYDE and 5-fluorouracil/folinic acid for treating pancreatic cancer. In December 2019, XBiotech's drug for dermatological conditions, bermekimab, was acquired by Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, for $750 million. XBiotech is eligible for up to $600 million in milestone payments, potentially increasing the total value of the deal to $1.35 billion. In February 2022, Johnson & Johnson discontinued development of bermekimab for eczema taking a $610 million pretax impairment charge. As of January 2023, bermekimab is no longer being developed for hidradenitis suppurativa. During the COVID-19 pandemic, XBiotech worked with BioBridge Global to offer its antibody screening technology to the South Texas Blood & Tissue Center. The technology identified patients with natural antibodies effective against the virus. XBiotech also developed a COVID-19 therapy candidate by isolating specific antibodies and their genes from convalescent plasma, aiming to create a mass-producible, purified antibody product.

Xilonix XBiotech is known for developing Xilonix, a candidate therapeutic for treating advanced colorectal cancer by targeting tumor-associated inflammation, an approach intended to inhibit both tumor growth and metastasis. Xilonix received fast-track designation from the United States Food and Drug Administration in 2012 and had progressed to Phase 3 trials in both the United States and Europe by 2016. In February 2017, XBiotech reported in an SEC filing that it had received an extension from European regulators to address deficiencies the agency was asserting in the registration application. The company indicated it expected to meet the new deadline of March 22 to respond to these issues.

References

Worked examples

Example 1 — a first encounter with XBiotech

Start with the simplest possible case. Write down what XBiotech claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to XBiotech before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about XBiotech ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of XBiotech

In research
XBiotech appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses XBiotech in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
XBiotech is common in secondary-school and first-year university syllabi. It links to neighbouring topics 2005 establishments in Canada, Companies based in Austin, Texas, Companies listed on the Nasdaq, so understanding it makes those chapters shorter.
In everyday life
Look for XBiotech outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “XBiotech” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study XBiotech in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what XBiotech means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain XBiotech out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is XBiotech in simple terms?

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

Why does XBiotech matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study XBiotech?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on XBiotech.

Tags

  • 2005 establishments in Canada
  • Companies based in Austin, Texas
  • Companies listed on the Nasdaq
  • Pharmaceutical companies
  • Pharmaceutical companies established in 2005

Keep exploring